Trade VRXA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Veraxa Biotech AG (VRXA) is trading at US$1.76, up 15.03% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$275.75M. Over the past 52 weeks, VRXA has traded between US$1.27 and US$27.36. On Syfe you can trade VRXA with $0 commission and add it to your watchlist.
| Previous close | US$1.53 |
|---|---|
| Market cap | US$275.75M |
| 52-week range | US$1.27 – US$27.36 |
| Volume | 3.55M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Veraxa Biotech AG
Veraxa Biotech Holding AG engages in operating an oncology-focused biotechnology company, which is the Veraxa Biotech AG (Company). The Company focuses on the development of novel antibody-based drug platforms for the treatment of cancer. The company was founded on June 25, 2025 and is headquartered in Zurich, Switzerland.
Year: 2026
Veraxa Biotech Advances Bispecific Antibody Drug Conjugate Program
Jul 27, 11:57 AM · MT Newswires
Veraxa Biotech Receives Regulatory Guidance for BiTAC-TCE Cancer Therapy Program
Jul 20, 12:14 PM · MT Newswires
Veraxa Collaborates With Ardigen to Use AI for Cancer Drug Development
Jul 13, 12:14 PM · MT Newswires
Veraxa Biotech AG (VRXA) stock is trading at US$1.76, +15.03% from the previous close of US$1.53.
The market cap for Veraxa Biotech AG (VRXA) stock is approximately US$275.75M.
The 52-week high for Veraxa Biotech AG (VRXA) stock is US$27.36.
The 52-week low for Veraxa Biotech AG (VRXA) stock is US$1.27.
Veraxa Biotech AG (VRXA) does not currently pay a dividend.
Stay on top of VRXA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
